Meet Singota's 'Dr. Impossible': How Singota Senior Formulation Scientist Shehaab Savliwala Tackles Complex Formulation Challenges

Dr. Shehaab Savliwala, a Senior Formulation Scientist at Singota Solutions, is known for his expertise in solving complex drug formulation challenges. Nicknamed "Dr. Impossible" by colleagues, Shehaab specializes in nanoparticle formulations, in-use stability testing, and injectable pharmaceutical development. His work focuses on optimizing drug encapsulation to enhance bioavailability, stability, and controlled release.

Born and raised in Maharashtra, India, Shehaab developed a passion for chemical engineering and nanomedicine early in his academic journey. His graduate research at the University of Florida earned over 800 citations across 13 peer-reviewed publications and presentations. A highlight of his career was his work on Magnetic Particle Imaging (MPI), a cutting-edge medical imaging technology. His contributions led to a patented innovation that enhances MPI and MRI imaging using biocompatible iron oxide nanoparticles to improve drug delivery visualization.

At Singota, Shehaab applies his deep scientific knowledge to accelerate pharmaceutical development for clients. His experience spans early-stage drug formulation, Phase 1-3 GMP manufacturing, and analytical method development. Singota’s adaptable, innovation-driven culture attracted Shehaab, as the company specializes in supporting early-phase clients with tailored solutions.

Beyond his work, Shehaab is part of the Cheeky Scientist Association, a global network of PhDs supporting career advancement in scientific industries. He credits this community for helping him transition into his role at Singota.

For more information - visit www.singota.com